Nursing Review Issue 2 | Mar-Apr 2018 | Page 4

news Boost for mental health nurses New project to update mental health content of nursing degrees. T he federal government has committed $128,000 to fund mental health course materials for undergraduate nursing degrees across the country. The minister for rural health, Senator Bridget McKenzie, said the funding would be provided to the Australian College of Mental Health Nurses to undertake the Improving Mental Health Content in Undergraduate Nursing project. “Australians – including people living in rural areas – deserve top quality healthcare, whenever and wherever they need it. Mental health is central to this,” McKenzie said. “Nurses and midwives are the largest professional group in the health workforce. They play a vitally important role in providing care to Australians every day and are the front line of our health services in rural and remote areas. “This project will take a detailed look at the current mental health content of undergraduate nursing degrees and clinical nursing placements in mental health settings.” McKenzie said that as more Australians recognised the impact of mental health Vitamin B3 to treat glaucoma? Melbourne researchers conducting world‑first human trial to treat glaucoma. A humble vitamin B3 supplement could be the key to treating glaucoma, new research has found. Melbourne’s Centre for Eye Research Australia (CERA) is in the midst of conducting a world-first human trial that uses vitamin B3 to treat the disease of the optic nerve. 2 | nursingreview.com.au issues, it was important that Australia’s health workforce was equipped to provide the best possible care and support. “Improving mental healthcare is a key priority for the Coalition government, and we are committed to transforming the way mental healthcare is delivered in Australia,” McKenzie said. “Projects like this will ensure mental health content being taught in nursing programs equips our workforce to respond to mental health challenges on the front line. “The Coalition government recognises around four million Australians experience mental health conditions every year and that’s why we are committed to delivering vital mental health services.” The findings of the project will assist in the development of a national framework for mental health content in undergraduate nursing programs. This framework will then be distributed to Australian universities, and will inform the Australian Nursing and Midwifery Accreditation Council review of registered nurse standards. ■ Research fellow Dr Flora Hui said the six-month clinical trial aimed to use a high dose of the vitamin to support existing glaucoma therapies such as daily eye drops. “Imagine your car’s engine is running a bit rough, and as a result the car doesn’t drive smoothly. If you top up the engine with oil, the car runs better, even though you haven’t fixed the underlying problem,” Dr Hui said. “Our study hopes to confirm that vitamin B3 can protect nerve cells from dying, in a similar way that adding oil to a faulty car engine can still allow it to run more smoothly.” CERA managing director and research leader Jonathan Crowston said glaucoma affects 60 million people worldwide. “Glaucoma currently has no cure and vision loss is generally thought to be irreversible,” he said. “We have recently discovered that in the early stages after an injury, visual function can in fact recover, but that the ability to recover diminishes with increasing age. “We have developed clinical tests that now allow us to look for visual recovery in the clinic and are beginning to look at treatment that could boost recovery. “Our premise is that if you can improve optic nerve recovery after an injury then we can reduce the risk of glaucoma progressing.” In 2017, a US research team led by JAX Laboratories’ Professor Simon John and Dr Pete Williams found that vitamin B3 given to glaucoma-prone mice prevented optic nerve degeneration and glaucoma. This treatment also reversed the negative effects of ageing in the mice’s eyes. “We were very excited by these findings and are now looking at the effect of vitamin B3 in glaucoma patients,” Crowston said. ■